FIELD: pharmaceutical chemistry. SUBSTANCE: composition contains lipophilic sparingly soluble active substance in the form of liposomes, at least one phospholipid, distilled water, special adjuvants, and, additionally, at least one fatty acid with general formula H3C-(CH2)P-COOH, wherein n is 4 to 8, or salt of this acid at specified ratio of components. EFFECT: increased physico-chemical stability. 6 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COLLOIDAL SOLUTION | 2008 |
|
RU2449776C2 |
PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES | 2011 |
|
RU2571283C2 |
LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
BILAYER PREPARATIONS | 1995 |
|
RU2166332C2 |
ERYTHROPOIETIN LIPOSOMAL DISPERSION | 1999 |
|
RU2218914C2 |
METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
METHOD FOR PRODUCING LIPOSOMAL AGENT EXHIBITING WOUND HEALING ACTION | 2009 |
|
RU2417075C1 |
IMPROVED LIPOSOMAL COMPOSITIONS OF LIPOPHILIC COMPOUNDS | 2011 |
|
RU2641605C2 |
COSMETIC AND/OR PHARMACEUTICAL COMPOSITION RELIEVING PRURITUS | 1996 |
|
RU2178692C2 |
Authors
Dates
2000-12-10—Published
1995-09-11—Filed